United Capital Financial Advisers, LLC Moderna, Inc. Transaction History

United Capital Financial Advisers, LLC

$11.5 Billion
Q2 2024

A detailed history of United Capital Financial Advisers, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, United Capital Financial Advisers, LLC holds 10,787 shares of MRNA stock, worth $709,245. This represents 0.01% of its overall portfolio holdings.

Number of Shares

10,787

Previous 9,904 8.92%

Holding current value

$709,245

Previous $1.06 Million 21.33%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$101.21 - $166.61 $89,368 - $147,116	883 Added 8.92%	10,787 $1.28 Million
Q1 2024 May 15, 2024	BUY	$85.37 - $115.44 $95,955 - $129,754	1,124 Added 12.8%	9,904 $1.06 Million
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $212,144 - $318,720	3,052 Added 53.28%	8,780 $873,000
Q3 2023 Nov 14, 2023	SELL	$96.41 - $126.61 $187,035 - $245,623	-1,940 Reduced 25.3%	5,728 $591,000
Q2 2023 Aug 14, 2023	SELL	$118.5 - $160.53 $213,300 - $288,954	-1,800 Reduced 19.01%	7,668 $931,000
Q1 2023 Aug 14, 2023	BUY	$135.66 - $197.02 $244,188 - $354,636	1,800 Added 23.47%	9,468 $1.45 Million
Q1 2023 May 15, 2023	SELL	$135.66 - $197.02 $320,021 - $464,770	-2,359 Reduced 19.95%	9,468 $1.45 Million
Q4 2022 Feb 14, 2023	BUY	$118.38 - $210.04 $31,607 - $56,080	267 Added 2.31%	11,827 $2.12 Million
Q3 2022 Nov 14, 2022	BUY	$118.07 - $194.18 $80,287 - $132,042	680 Added 6.25%	11,560 $1.37 Million
Q2 2022 Aug 11, 2022	SELL	$117.13 - $176.59 $44,040 - $66,397	-376 Reduced 3.34%	10,880 $1.55 Million
Q1 2022 May 16, 2022	SELL	$126.46 - $235.05 $73,473 - $136,564	-581 Reduced 4.91%	11,256 $1.94 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $46,067 - $75,176	-204 Reduced 1.69%	11,837 $3.01 Million
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $41,717 - $91,080	188 Added 1.59%	12,041 $4.63 Million
Q2 2021 Aug 13, 2021	BUY	$129.91 - $234.98 $18,577 - $33,602	143 Added 1.22%	11,853 $2.79 Million
Q1 2021 May 14, 2021	SELL	$109.18 - $185.98 $19,215 - $32,732	-176 Reduced 1.48%	11,710 $1.53 Million
Q4 2020 Feb 17, 2021	BUY	$65.74 - $169.86 $127,667 - $329,868	1,942 Added 19.53%	11,886 $1.24 Million
Q3 2020 Nov 13, 2020	BUY	$54.34 - $94.85 $253,822 - $443,044	4,671 Added 88.58%	9,944 $704,000
Q2 2020 Aug 13, 2020	BUY	$29.67 - $80.0 $156,449 - $421,840	5,273 New	5,273 $339,000

Others Institutions Holding MRNA

# of Institutions

1,113

Shares Held

241M

Call Options Held

9.26M

Put Options Held

12.1M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of United Capital Financial Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on United Capital Financial Advisers, LLC with notifications on news.

Account

United Capital Financial Advisers, LLC Moderna, Inc. Transaction History